Double blind, randomised, prospective placebo controlled parallel group phase III study to investigate the Effect of EGCG supplementation on disease progression of patients with Multiple System Atrophy (MSA) Double blind, randomised, prospective placebo controlled parallel group phase III study to investiga ...
Double blind, randomised, prospective placebo controlled parallel group phase III study to investigate the Effect of EGCG supplementation on disease progression of patients with Multiple System Atrophy (MSA) - Progression Rate of MSA under EGCG Supplementation as anti-Aggregation-Approach Double blind, randomised, prospective placebo controlled parallel group phase III study to investiga ...
Progression of patients with Multiple System Atrophy (MSA);Therapeutic area: Diseases [C] - Nervous System Diseases [C10] Progression of patients with Multiple System Atrophy (MSA);Therapeutic area: Diseases [C] - Nervous ...
Trade Name: Sunphenon EGCg INN or Proposed INN: EGCG Other descriptive name: GREEN TEALEAF
Hospital of the Ludwig-Maximilians-University of Munich